These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 39588146)
1. Delayed immune-related adverse events profile associated with immune checkpoint inhibitors: a real-world analysis. Yang Y; Li L; Tian J; Ma L; Wu Y; Luo Q; Luo Y Front Pharmacol; 2024; 15():1453429. PubMed ID: 39588146 [TBL] [Abstract][Full Text] [Related]
2. Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences. Pillay J; Gaudet LA; Saba S; Vandermeer B; Ashiq AR; Wingert A; Hartling L Syst Rev; 2024 Nov; 13(1):289. PubMed ID: 39593159 [TBL] [Abstract][Full Text] [Related]
3. Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone. Lee CC; Chen CW; Yen HK; Lin YP; Lai CY; Wang JL; Groot OQ; Janssen SJ; Schwab JH; Hsu FM; Lin WH Clin Orthop Relat Res; 2024 Dec; 482(12):2193-2208. PubMed ID: 39051924 [TBL] [Abstract][Full Text] [Related]
4. Pharmacological treatments in panic disorder in adults: a network meta-analysis. Guaiana G; Meader N; Barbui C; Davies SJ; Furukawa TA; Imai H; Dias S; Caldwell DM; Koesters M; Tajika A; Bighelli I; Pompoli A; Cipriani A; Dawson S; Robertson L Cochrane Database Syst Rev; 2023 Nov; 11(11):CD012729. PubMed ID: 38014714 [TBL] [Abstract][Full Text] [Related]
5. Toxicity profiles of immune checkpoint inhibitors in nervous system cancer: a comprehensive disproportionality analysis using FDA adverse event reporting system. Liu R; Zhao H; Lu Z; Zeng L; Shi H; Wu L; Wang J; Zhong F; Liu C; Zhang Y; Qiu Z Clin Exp Med; 2024 Sep; 24(1):216. PubMed ID: 39249163 [TBL] [Abstract][Full Text] [Related]
6. Real-world study of adverse events associated with triptan use in migraine treatment based on the U.S. Food and Drug Administration (FDA) adverse event reporting system (FAERS) database. Liu WH; Hu HM; Li C; Shi Q; Liu CH; Liu AX; Li YF; Zhang Y; Mao P; Fan BF J Headache Pain; 2024 Nov; 25(1):206. PubMed ID: 39587512 [TBL] [Abstract][Full Text] [Related]
7. Tamoxifen for adults with hepatocellular carcinoma. Naing C; Ni H; Aung HH Cochrane Database Syst Rev; 2024 Aug; 8(8):CD014869. PubMed ID: 39132750 [TBL] [Abstract][Full Text] [Related]
8. Lamotrigine versus levetiracetam or zonisamide for focal epilepsy and valproate versus levetiracetam for generalised and unclassified epilepsy: two SANAD II non-inferiority RCTs. Marson AG; Burnside G; Appleton R; Smith D; Leach JP; Sills G; Tudur-Smith C; Plumpton CO; Hughes DA; Williamson PR; Baker G; Balabanova S; Taylor C; Brown R; Hindley D; Howell S; Maguire M; Mohanraj R; Smith PE Health Technol Assess; 2021 Dec; 25(75):1-134. PubMed ID: 34931602 [TBL] [Abstract][Full Text] [Related]
9. Cancer type and histology influence cutaneous immunotherapy toxicities: a multi-institutional cohort study. Wan G; Khattab S; Leung BW; Zhang S; Nguyen N; Tran M; Lin C; Chang C; Alexander N; Jairath R; Phillipps J; Tang K; Rajeh A; Zubiri L; Chen ST; Demehri S; Yu KH; Gusev A; Kwatra SG; LeBoeuf NR; Reynolds KL; Semenov YR Br J Dermatol; 2024 Jun; 191(1):117-124. PubMed ID: 38366637 [TBL] [Abstract][Full Text] [Related]
10. Qualitative evidence synthesis informing our understanding of people's perceptions and experiences of targeted digital communication. Ryan R; Hill S Cochrane Database Syst Rev; 2019 Oct; 10(10):ED000141. PubMed ID: 31643081 [TBL] [Abstract][Full Text] [Related]
11. Differences in hypersensitivity reactions and gadolinium deposition disease/symptoms associated with gadolinium exposure to gadolinium-based contrast agents: new insights based on global databases VigiBase, FAERS, and IQVIA-MIDAS. Qu H; Li W; Wu Z; Wang Y; Feng T; Li N; Qi C; Li X; Wei T; Fan G; Lou Y BMC Med; 2024 Aug; 22(1):329. PubMed ID: 39135199 [TBL] [Abstract][Full Text] [Related]
12. Neurologic Outcomes in People With Multiple Sclerosis Treated With Immune Checkpoint Inhibitors for Oncologic Indications. Quinn CM; Rajarajan P; Gill AJ; Kopinsky H; Wolf AB; de Camargo CS; Lamb J; Bacon TE; Murray JC; Probasco JC; Galetta KM; Kantor D; Coyle P; Bhise V; Alvarez E; Conway SE; Bhattacharyya S; Kister I Neurology; 2024 Dec; 103(11):e210003. PubMed ID: 39541548 [TBL] [Abstract][Full Text] [Related]
14. What Are the Functional, Radiographic, and Survivorship Outcomes of a Modified Cup-cage Technique for Pelvic Discontinuity? Mu W; Xu B; Wahafu T; Wang F; Guo W; Zou C; Cao L Clin Orthop Relat Res; 2024 Dec; 482(12):2149-2160. PubMed ID: 38991223 [TBL] [Abstract][Full Text] [Related]
15. Interventions to prevent surgical site infection in adults undergoing cardiac surgery. ; Rogers LJ; Vaja R; Bleetman D; Ali JM; Rochon M; Sanders J; Tanner J; Lamagni TL; Talukder S; Quijano-Campos JC; Lai F; Loubani M; Murphy GJ Cochrane Database Syst Rev; 2024 Dec; 12(12):CD013332. PubMed ID: 39620424 [TBL] [Abstract][Full Text] [Related]
16. Trends in Surgical and Nonsurgical Aesthetic Procedures: A 14-Year Analysis of the International Society of Aesthetic Plastic Surgery-ISAPS. Triana L; Palacios Huatuco RM; Campilgio G; Liscano E Aesthetic Plast Surg; 2024 Oct; 48(20):4217-4227. PubMed ID: 39103642 [TBL] [Abstract][Full Text] [Related]
17. A multicomponent psychosocial intervention to reduce substance use by adolescents involved in the criminal justice system: the RISKIT-CJS RCT. Coulton S; Nizalova O; Pellatt-Higgins T; Stevens A; Hendrie N; Marchand C; Vass R; Deluca P; Drummond C; Ferguson J; Waller G; Newbury-Birch D Public Health Res (Southampt); 2023 Mar; 11(3):1-77. PubMed ID: 37254608 [TBL] [Abstract][Full Text] [Related]